Going anti-Viral

By: Going Anti-Viral
  • Summary

  • Introducing Going anti-Viral, the podcast of the IAS–USA, a professional continuing medical education organization focused on HIV and other viral diseases. I’m Dr Michael Saag, professor emeritus of medicine and infectious diseases at the University of Alabama at Birmingham and volunteer member of the IAS–USA Board of Directors.
    Join us as we interview experts in viral medicine about their area of specialty and current developments in the field. Other episodes are drawn from the IAS-USA vast catalogue of panel discussions, Dialogues, and various meetings and conferences.
    Going anti-Viral is a podcast series for clinicians, produced by the International Antiviral Society–USA. The IAS–USA is a not-for-profit professional organization committed to improving the treatment, care, and quality of life for people with or at risk for HIV or other viral infections and their complications through balanced education and information. This podcast is intended as a technical source of information for specialists in this field, but we hope anyone listening will enjoy learning more about the state of modern medicine around viral infections and their consequences.

    © 2024 Going anti-Viral
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • Episode 30 - Update on Mpox - a Public Health Emergency - Dr Jason Zucker
    Nov 5 2024

    In this episode of Going anti-Viral, Dr Michael Saag speaks with Dr Jason Zucker of Columbia University and the New York City STD Prevention Training Center about mpox and the mpox outbreak. Dr Saag and Dr Zucker discuss the 2 clades of mpox, how it is transmitted, and which clade is associated with the most recent mpox outbreak. They also discuss how to test for mpox and how people with HIV present with mpox based on their HIV viral load. Dr Zucker gives a detailed update on the STOMP (Study of Tecovirimat for Human Mpox Virus) trial that evaluates the efficacy of the antiviral tecovirimat, also known as TPOXX, for the treatment of mpox. They also address the role of vaccination in mpox, its uptake and efficacy. Finally, Dr Zucker offers his perspective on how practitioners and public health officials can address ongoing mpox outbreaks in the US and globally, including a second public health emergency of international concern that was declared in the Democratic Republic of the Congo and surrounding countries in August by the World Health Organization (WHO).

    0:00 – Introduction

    1:25 – Description of mpox and its 2 clades

    2:07 – Overview of the current mpox outbreak

    3:11 – Mpox transmission

    4:29 – Mpox in people with HIV

    6:35 – Testing for mpox

    9:05 – The STOMP study, enrollment, and effectiveness of tecovirimat

    15:58 – The role for vaccination for mpox and who should receive it

    20:38 – Outlook for the future

    __________________________________________________

    Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.

    Going anti-Viral’s host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences.

    Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.

    Follow Going anti-Viral on:
    Apple Podcasts
    YouTube
    X
    Facebook
    Instagram
    ...

    Show more Show less
    24 mins
  • Episode 29 - Comparing and Contrasting Health Care Policies from different sides of the Aisle - Dr Jennifer Kates
    Oct 22 2024

    In this episode of Going anti-Viral, Dr Michael Saag speaks with Dr Jennifer Kates of KFF to compare and contrast health care policies from different sides of the aisle. Dr Kates provides an update on the Patient Protection and Affordable Care Act (ACA) and efforts to repeal the healthcare program in the United States. Dr Saag and Dr Kates also discuss the status of Medicaid expansion in the US and the impact of access to care in states where Medicaid has been expanded. They also discuss the impact of the Ryan White HIV/AIDS Program on healthcare for people with HIV and the long-term outlook for funding for the program. In addition, there is a detailed overview and outlook of funding for the 340B Drug Pricing Program that allows eligible hospitals and other healthcare organizations to purchase outpatient drugs at a discount from pharmaceutical manufacturers. Finally, Dr Saag and Dr Kates discuss the erosion of trust in science and public health officials in the US and reasons to be optimistic for the future.

    0:00 – Introduction

    1:15 – Update on the ACA

    3:19 – Discussion of efforts to repeal the ACA

    5:32 – Status of Medicaid expansion in the US

    8:56 – Overview of access to HIV care through Ryan White

    10:37 – Access to health insurance coverage through Ryan White

    12:31 – What is 340B funding?

    15:45 – Possible pressures on 340B funding

    17:45 – Outlook for Ryan White funding and availability of PrEP in the program

    21:34 – Discussion of the erosion of trust in science and public health

    26:42 – Outlook for the future

    __________________________________________________

    Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.

    Going anti-Viral’s host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences.

    Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.

    Follow Going anti-Viral on:
    Apple Podcasts
    YouTube
    X
    Facebook
    Instagram
    ...

    Show more Show less
    29 mins
  • Episode 28: Special Episode - Latest Update on Urgent Virus Outbreaks: October 2024
    Oct 15 2024

    This episode of Going anti-Viral features an IAS–USA Dialogue titled "Latest Update on Urgent Viral Outbreaks," a panel discussion held on October 4, 2024. Dr Carlos del Rio from Emory University serves as moderator and welcomes 3 distinguished panelists: Dr Yvonne Maldonado from Stanford University, Dr Peter Chin-Hong from the University of California San Francisco, and Dr Paul Sax from Brigham and Women’s Hospital.

    The episode covers various pressing topics, including updates on COVID-19, avian flu, mpox, and other viral diseases. Discussions touch on vaccines, their effectiveness, public health approaches, and current research.

    0:00 – Introduction and overview of ongoing viral outbreaks

    3:59 – Update on respiratory viruses and vaccination – seasonal flu, RSV, and COVID-19

    12:17 – Discussion of monoclonal antibody treatment for COVID-19

    14:15 – Update on the use of Paxlovid for COVID-19

    18:48 – COVID-19 vaccination – protein vaccines vs. mRNA vaccines

    22:48 – Update on pertussis

    28:54 – Discussion of seasonal influenza and vaccination

    32:55 – Effectiveness of shingles and RSV vaccines

    35:57 – Discussion of vaccination during pregnancy

    40:02 – Audience questions

    43:04 – Update on H5N1 (avian flu) outbreak

    52:00 – Update on Marburg virus outbreak in Rwanda

    55:43 – Discussion of mpox outbreak in central Africa

    59:29 – Concluding remarks

    __________________________________________________

    Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.

    Going anti-Viral’s host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences.

    Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.

    Follow Going anti-Viral on:
    Apple Podcasts
    YouTube
    X
    Facebook
    Instagram
    ...

    Show more Show less
    1 hr and 2 mins

What listeners say about Going anti-Viral

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.